Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention

Maria G. Frank; Gretchen Weaver; Vanessa Raabe; Richard T. Davey; Noreen A. Hynes; Mark G. Kortepeter; Nahid Bhadelia; Kerry Dierberg; Aneesh K. Mehta; Corri B. Levine; Peter C. Iwen; Denis A. Bente; Justin Chan; Adam Beitscher

doi:10.3201/eid3005.231647

Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention

Maria G. Frank, Gretchen Weaver, Vanessa Raabe, Richard T. Davey, Noreen A. Hynes, Mark G. Kortepeter, Nahid Bhadelia, Kerry Dierberg, Aneesh K. Mehta, Corri B. Levine, Peter C. Iwen, Denis A. Bente, Justin Chan, Adam Beitscher

Microbiology And Immunology

Research output: Contribution to journal › Review article › peer-review

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a tickborne infection that can range from asymptomatic to fatal and has been described in >30 countries. Early identification and isolation of patients with suspected or confirmed CCHF and the use of appropriate prevention and control measures are essential for preventing human-to-human transmission. Here, we provide an overview of the epidemiology, clinical features, and prevention and control of CCHF. CCHF poses a continued public health threat given its wide geographic distribution, potential to spread to new regions, propensity for genetic variability, and potential for severe and fatal illness, in addition to the limited medical countermeasures for prophylaxis and treatment. A high index of suspicion, comprehensive travel and epidemiologic history, and clinical evaluation are essential for prompt diagnosis. Infection control measures can be effective in reducing the risk for transmission but require correct and consistent application.

Original language	English (US)
Pages (from-to)	854-863
Number of pages	10
Journal	Emerging infectious diseases
Volume	30
Issue number	5
DOIs	https://doi.org/10.3201/eid3005.231647
State	Published - May 2024

ASJC Scopus subject areas

Epidemiology
Microbiology (medical)
Infectious Diseases

Access to Document

10.3201/eid3005.231647

Cite this

Frank, M. G., Weaver, G., Raabe, V., Davey, R. T., Hynes, N. A., Kortepeter, M. G., Bhadelia, N., Dierberg, K., Mehta, A. K., Levine, C. B., Iwen, P. C., Bente, D. A., Chan, J., & Beitscher, A. (2024). Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention. Emerging infectious diseases, 30(5), 854-863. https://doi.org/10.3201/eid3005.231647

Frank, MG, Weaver, G, Raabe, V, Davey, RT, Hynes, NA, Kortepeter, MG, Bhadelia, N, Dierberg, K, Mehta, AK, Levine, CB, Iwen, PC, Bente, DA, Chan, J & Beitscher, A 2024, 'Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention', Emerging infectious diseases, vol. 30, no. 5, pp. 854-863. https://doi.org/10.3201/eid3005.231647

@article{6f253d720d8f4f44998eb3c391afe016,

title = "Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention",

abstract = "Crimean-Congo hemorrhagic fever (CCHF) is a tickborne infection that can range from asymptomatic to fatal and has been described in >30 countries. Early identification and isolation of patients with suspected or confirmed CCHF and the use of appropriate prevention and control measures are essential for preventing human-to-human transmission. Here, we provide an overview of the epidemiology, clinical features, and prevention and control of CCHF. CCHF poses a continued public health threat given its wide geographic distribution, potential to spread to new regions, propensity for genetic variability, and potential for severe and fatal illness, in addition to the limited medical countermeasures for prophylaxis and treatment. A high index of suspicion, comprehensive travel and epidemiologic history, and clinical evaluation are essential for prompt diagnosis. Infection control measures can be effective in reducing the risk for transmission but require correct and consistent application.",

author = "Frank, {Maria G.} and Gretchen Weaver and Vanessa Raabe and Davey, {Richard T.} and Hynes, {Noreen A.} and Kortepeter, {Mark G.} and Nahid Bhadelia and Kerry Dierberg and Mehta, {Aneesh K.} and Levine, {Corri B.} and Iwen, {Peter C.} and Bente, {Denis A.} and Justin Chan and Adam Beitscher",

year = "2024",

month = may,

doi = "10.3201/eid3005.231647",

language = "English (US)",

volume = "30",

pages = "854--863",

journal = "Emerging infectious diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "5",

}

TY - JOUR

T1 - Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention

AU - Frank, Maria G.

AU - Weaver, Gretchen

AU - Raabe, Vanessa

AU - Davey, Richard T.

AU - Hynes, Noreen A.

AU - Kortepeter, Mark G.

AU - Bhadelia, Nahid

AU - Dierberg, Kerry

AU - Mehta, Aneesh K.

AU - Levine, Corri B.

AU - Iwen, Peter C.

AU - Bente, Denis A.

AU - Chan, Justin

AU - Beitscher, Adam

PY - 2024/5

Y1 - 2024/5

N2 - Crimean-Congo hemorrhagic fever (CCHF) is a tickborne infection that can range from asymptomatic to fatal and has been described in >30 countries. Early identification and isolation of patients with suspected or confirmed CCHF and the use of appropriate prevention and control measures are essential for preventing human-to-human transmission. Here, we provide an overview of the epidemiology, clinical features, and prevention and control of CCHF. CCHF poses a continued public health threat given its wide geographic distribution, potential to spread to new regions, propensity for genetic variability, and potential for severe and fatal illness, in addition to the limited medical countermeasures for prophylaxis and treatment. A high index of suspicion, comprehensive travel and epidemiologic history, and clinical evaluation are essential for prompt diagnosis. Infection control measures can be effective in reducing the risk for transmission but require correct and consistent application.

AB - Crimean-Congo hemorrhagic fever (CCHF) is a tickborne infection that can range from asymptomatic to fatal and has been described in >30 countries. Early identification and isolation of patients with suspected or confirmed CCHF and the use of appropriate prevention and control measures are essential for preventing human-to-human transmission. Here, we provide an overview of the epidemiology, clinical features, and prevention and control of CCHF. CCHF poses a continued public health threat given its wide geographic distribution, potential to spread to new regions, propensity for genetic variability, and potential for severe and fatal illness, in addition to the limited medical countermeasures for prophylaxis and treatment. A high index of suspicion, comprehensive travel and epidemiologic history, and clinical evaluation are essential for prompt diagnosis. Infection control measures can be effective in reducing the risk for transmission but require correct and consistent application.

UR - http://www.scopus.com/inward/record.url?scp=85191504998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85191504998&partnerID=8YFLogxK

U2 - 10.3201/eid3005.231647

DO - 10.3201/eid3005.231647

M3 - Review article

C2 - 38666548

AN - SCOPUS:85191504998

SN - 1080-6040

VL - 30

SP - 854

EP - 863

JO - Emerging infectious diseases

JF - Emerging infectious diseases

IS - 5

ER -

Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this